FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898089944> ?p ?o ?g. }

• W2898089944 endingPage "1263" @default.
• W2898089944 startingPage "1257" @default.
• W2898089944 abstract "Objective: The effectiveness of golimumab in Crohn’s disease (CD) is largely unknown as it is not approved for the treatment of the disease. We aimed to identify the population of CD patients treated with golimumab in Sweden, to assess the effectiveness of golimumab (defined as the drug retention rate), and to identify predictors of drug discontinuation.Methods: Patients with CD who received at least one injection of golimumab were identified through the Swedish National Quality Registry for Inflammatory Bowel Disease, which includes prospectively collected clinical information. Cox regression models were used to identify predictors of golimumab discontinuation.Results: The study cohort involved 94 patients of whom the majority (96.8%) had previously discontinued at least one anti-tumour necrosis factor (anti-TNF) agent. The drug retention rate at 12 weeks was 85.1%. Predictors of golimumab discontinuation at 12 weeks were previous surgery (adjusted HR = 7.52, 95% CI: 1.12–50.36), concomitant corticosteroid use at baseline (adjusted HR = 5.70, 95% CI: 1.13–28.68) and female sex (adjusted HR = 6.59; 95% CI: 1.04–41.62). The median duration of follow-up was 89 (IQR: 32–158) weeks. The drug retention at the most recent follow-up was 35.1%. Predictors of golimumab discontinuation at the most recent follow-up were corticosteroid use at baseline (adjusted HR = 2.60, 95% CI: 1.17–5.79) and female sex (adjusted HR = 2.24; 95% CI: 1.19–4.23).Conclusion: Patients with CD treated with golimumab were a treatment-refractory group. Despite this, more than one-third of the patients appeared to have had clinical benefit after a median follow-up of more than 1.5 years." @default.
• W2898089944 created "2018-11-02" @default.
• W2898089944 creator A5000300261 @default.
• W2898089944 creator A5013997524 @default.
• W2898089944 creator A5014003957 @default.
• W2898089944 creator A5017335255 @default.
• W2898089944 creator A5018985193 @default.
• W2898089944 creator A5019252027 @default.
• W2898089944 creator A5019763510 @default.
• W2898089944 creator A5019938824 @default.
• W2898089944 creator A5019960092 @default.
• W2898089944 creator A5024055027 @default.
• W2898089944 creator A5068091489 @default.
• W2898089944 creator A5087768306 @default.
• W2898089944 date "2018-10-24" @default.
• W2898089944 modified "2023-10-02" @default.
• W2898089944 title "Clinical effectiveness of golimumab in Crohn’s disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)" @default.
• W2898089944 cites W1471622042 @default.
• W2898089944 cites W1486205675 @default.
• W2898089944 cites W1940760407 @default.
• W2898089944 cites W1984705525 @default.
• W2898089944 cites W1990402037 @default.
• W2898089944 cites W2016709601 @default.
• W2898089944 cites W2020640954 @default.
• W2898089944 cites W2022912279 @default.
• W2898089944 cites W2080037503 @default.
• W2898089944 cites W2094778049 @default.
• W2898089944 cites W2121609590 @default.
• W2898089944 cites W2166021109 @default.
• W2898089944 cites W2321142731 @default.
• W2898089944 cites W2404971681 @default.
• W2898089944 cites W2523706394 @default.
• W2898089944 cites W2525802576 @default.
• W2898089944 cites W2546063853 @default.
• W2898089944 cites W2754846891 @default.
• W2898089944 cites W2764178891 @default.
• W2898089944 cites W2779439916 @default.
• W2898089944 cites W4233817719 @default.
• W2898089944 cites W4244626580 @default.
• W2898089944 doi "https://doi.org/10.1080/00365521.2018.1519597" @default.
• W2898089944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30353751" @default.
• W2898089944 hasPublicationYear "2018" @default.
• W2898089944 type Work @default.
• W2898089944 sameAs 2898089944 @default.
• W2898089944 citedByCount "8" @default.
• W2898089944 countsByYear W28980899442019 @default.
• W2898089944 countsByYear W28980899442020 @default.
• W2898089944 countsByYear W28980899442021 @default.
• W2898089944 countsByYear W28980899442022 @default.
• W2898089944 countsByYear W28980899442023 @default.
• W2898089944 crossrefType "journal-article" @default.
• W2898089944 hasAuthorship W2898089944A5000300261 @default.
• W2898089944 hasAuthorship W2898089944A5013997524 @default.
• W2898089944 hasAuthorship W2898089944A5014003957 @default.
• W2898089944 hasAuthorship W2898089944A5017335255 @default.
• W2898089944 hasAuthorship W2898089944A5018985193 @default.
• W2898089944 hasAuthorship W2898089944A5019252027 @default.
• W2898089944 hasAuthorship W2898089944A5019763510 @default.
• W2898089944 hasAuthorship W2898089944A5019938824 @default.
• W2898089944 hasAuthorship W2898089944A5019960092 @default.
• W2898089944 hasAuthorship W2898089944A5024055027 @default.
• W2898089944 hasAuthorship W2898089944A5068091489 @default.
• W2898089944 hasAuthorship W2898089944A5087768306 @default.
• W2898089944 hasBestOaLocation W28980899441 @default.
• W2898089944 hasConcept C126322002 @default.
• W2898089944 hasConcept C141071460 @default.
• W2898089944 hasConcept C201903717 @default.
• W2898089944 hasConcept C2778260677 @default.
• W2898089944 hasConcept C2778715236 @default.
• W2898089944 hasConcept C2779134260 @default.
• W2898089944 hasConcept C2780132546 @default.
• W2898089944 hasConcept C2781290027 @default.
• W2898089944 hasConcept C2908647359 @default.
• W2898089944 hasConcept C71924100 @default.
• W2898089944 hasConcept C72563966 @default.
• W2898089944 hasConcept C99454951 @default.
• W2898089944 hasConceptScore W2898089944C126322002 @default.
• W2898089944 hasConceptScore W2898089944C141071460 @default.
• W2898089944 hasConceptScore W2898089944C201903717 @default.
• W2898089944 hasConceptScore W2898089944C2778260677 @default.
• W2898089944 hasConceptScore W2898089944C2778715236 @default.
• W2898089944 hasConceptScore W2898089944C2779134260 @default.
• W2898089944 hasConceptScore W2898089944C2780132546 @default.
• W2898089944 hasConceptScore W2898089944C2781290027 @default.
• W2898089944 hasConceptScore W2898089944C2908647359 @default.
• W2898089944 hasConceptScore W2898089944C71924100 @default.
• W2898089944 hasConceptScore W2898089944C72563966 @default.
• W2898089944 hasConceptScore W2898089944C99454951 @default.
• W2898089944 hasIssue "10-11" @default.
• W2898089944 hasLocation W28980899441 @default.
• W2898089944 hasLocation W28980899442 @default.
• W2898089944 hasOpenAccess W2898089944 @default.
• W2898089944 hasPrimaryLocation W28980899441 @default.
• W2898089944 hasRelatedWork W2047967234 @default.
• W2898089944 hasRelatedWork W2062254869 @default.
• W2898089944 hasRelatedWork W2320301988 @default.
• W2898089944 hasRelatedWork W2439875401 @default.
• W2898089944 hasRelatedWork W2466043692 @default.

• next